Role of BMP Pathway in MDS Progression

Not yet recruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 27, 2024

Primary Completion Date

January 27, 2029

Study Completion Date

January 27, 2034

Conditions
Myelodysplastic SyndromesAcute Myelogenous Leukemia
Interventions
BIOLOGICAL

Collection of EDTA (disodium salt of ethylenediaminetetraacetic acid) tubes of marrow during routine care

When bone marrow is collected as part of a patient's care (diagnosis, follow-up, suspected AML/MDS hemopathy), one or two additional EDTA tubes of marrow are collected. Certain hematological data (NFP, genetic and molecular characteristics) will be collected in anonymized form and correlated with the BMP pathway alterations measured.

Trial Locations (1)

69229

Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT06175923 - Role of BMP Pathway in MDS Progression | Biotech Hunter | Biotech Hunter